Login / Signup

Portopulmonary hypertension: Success with combined medical treatment.

María HernándezVioleta EstebanPaloma RuizIgnacio BoiraPhillip WickmannJosé N Sancho-ChustJoan Gil
Published in: Respirology case reports (2023)
Portopulmonary hypertension is an uncommon disease associated with high morbidity and mortality, so its early diagnosis and treatment are essential. We report here the case of a 57-year-old man with portopulmonary hypertension caused by chronic hepatosplenic schistosomiasis and also liver cirrhosis due to hepatitis C and alcoholism. As well as treating both diseases, portopulmonary hypertension was successfully managed with tadalafil and macitentan as maintenance therapy. This case reminds clinicians that pulmonary hypertension can be multifactorial, a good diagnosis and a multidisciplinary treatment can lead to improved prognosis.
Keyphrases
  • blood pressure
  • pulmonary hypertension
  • healthcare
  • pulmonary arterial hypertension
  • stem cells
  • combination therapy
  • bone marrow
  • coronary artery
  • replacement therapy
  • quality improvement
  • arterial hypertension